Literature DB >> 2220170

[Local treatment of malignant pleural effusion in gynecologic tumors].

D Seitzer1, E Musch, W Kuhn.   

Abstract

Pleural effusions are a frequent complication of malignant gynecologic diseases, especially in breast cancer with an incidence of about 50%. Pleural effusions usually occur at a stage of the disease where no further curative therapeutic options exist. Therefore, the treatment should be effective and have a low side effect profile. The intrapleural administration of mitoxantrone in comparison with other pleurodesis techniques has been demonstrated to meet these requirements.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2220170

Source DB:  PubMed          Journal:  Zentralbl Gynakol        ISSN: 0044-4197


  2 in total

1.  Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer.

Authors:  Nikolaos Barbetakis; Theodoros Antoniadis; Christodoulos Tsilikas
Journal:  World J Surg Oncol       Date:  2004-05-20       Impact factor: 2.754

2.  Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer.

Authors:  Nikolaos Barbetakis; Michalis Vassiliadis; Konstantinos Kaplanis; Rosalia Valeri; Christodoulos Tsilikas
Journal:  BMC Palliat Care       Date:  2004-09-09       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.